- £1.25bn
- £2.45bn
- £150.40m
- 30
- 50
- 79
- 52
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 102 | 112 | 121 | 137 | 150 |
Cost of Revenue | |||||
Gross Profit | 95.2 | 104 | 112 | 127 | 138 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18.4 | 32.6 | 12.5 | -18.9 | 270 |
Operating Profit | 84 | 78.9 | 108 | 156 | -119 |
Net Income Before Taxes | 84 | 78.9 | 108 | 156 | -119 |
Provision for Income Taxes | |||||
Net Income After Taxes | 84 | 78.9 | 108 | 156 | -119 |
Net Income Before Extraordinary Items | |||||
Net Income | 84 | 78.9 | 108 | 156 | -119 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 84 | 78.9 | 108 | 156 | -119 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.035 | 0.033 | 0.043 | 0.056 | -0.04 |
Dividends per Share |